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pilepsy is a chronic disorder presented by recurrent episodes of seizures and affect worldwide 
individuals.  The underlying mechanism of seizure is still elusive. Hence, there is still a need to determine 
the contribution of various systems in neurobiology and treatment of seizure. Evidence shows that opioid 
and nitrergic systems within the brain interact to modulate various physiological and pathological 
conditions including memory, pain, reward, addiction, depression, and seizure. Various studies revealed that 
diverse dose of opioids such as morphine has dual modulation in seizure susceptibility. For instance, it is 
reported that morphine at lower doses (0.5, 1, and 3 mg/kg) exerts an anticonvulsant effect in experimental 
seizure models, whereas at higher doses (15, 30, and 60 mg/kg) it could exacerbate the seizure. Similarly, 
nitrergic system has also been observed to possess dual effects in modulating the seizure threshold. Therefore, 
understanding of opioidergic and nitrergic systems interaction in seizure seems important to achieve the 
successful goal of seizure management. This review aimed to clarify and provide insight into how opioidergic 
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Introduction  
Opioid system is a complex system involved in a diverse 
range of homeostatic functions. It is highly expressed 
throughout the brain, spinal cord, peripheral nervous 
systems, and in various other tissues. Interaction of 
various agents with endogenous opioids could cause 
both beneficial and adverse effects. Currently, its 
physiological and pharmacological effects are attributed 
by the activity of its three distinct receptors, mu, delta, 
and kappa. All are G protein-coupled receptors and are 
expressed both in presynaptic and postsynaptic 
neurons. Endogenous opioid peptides such as 
dynorphins, endorphins, enkephalins and the exogenous 
alkaloids such as morphine can activate these receptors. 
Recent research has reported new information on opioid 
receptor-mediated activities and their underlying 
phenomena with reference to seizure threshold. Opioid 
system involved in seizure modulation is extremely 
complex as both proconvulsant and anticonvulsant 
actions have been reported. Our previous experiments 
have revealed the involvement of specific opioid 
receptors in the proconvulsant and anticonvulsant 
effects, which are linked to interaction of opioids with 
nitric oxide (NO) system [1-10]. Therefore, information 
about the effects of this system is useful in understanding 
the susceptibility of seizure to various drugs and their 
doses, as well as the possible interaction with NO 
system. The present review aims to discuss the 
underlying mechanisms of opioids and NO system in 
seizure and finally to rearrange these pleiotropic actions 
in a comprehensive way.     
Methods 
Literature search strategy and selection criteria 
Literature concerned to these systems with their possible 
interaction was sorted out using key words such as 
morphine, opioids, nitric oxide and seizure in google 
scholar and web. The relevant literature based on their 
contents was selected and was pen down into this 
comprehensive and conceptual review. 
Discussion 
Opioids and epileptic seizures 
The effect of opioids on epileptic seizures is still 
controversial. Both proconvulsant and anticonvulsant 
effects of opioids such as tramadol [11] and morphine 
have been reported to be mediated by μ-(mu), δ-(delta), 
and κ-(kappa) opioid receptors (MOR, DOR, KOR, 
respectively) in various species including rats [12], 
human being [13], mice [14], and monkeys [15]. Rubaj 
etal. highlighted that normobaric hypoxia can reduce the 
susceptibility to pentylenetetrazole (PTZ)-induced 
convulsions, which could be mimicked by μ-or κ-receptor 
agonists in the brain [16]. In experimental epileptic 
models, it has been shown that epileptic seizures 
upregulate the opioid receptors [17], and potentiate the 
levels of endogenous opioid like enkephalins and 
dynorphins in the brain [18,19]. Opioids might possess 
anticonvulsant or proconvulsant effects in a dose-
dependent manner in the brain. For instance, other 
extensive studies confirmed that at low concentration, 
morphine diminishes the electrographic seizure, while 
exacerbates seizure activity in high concentrations [20]. 
In addition, in some early studies, it was found that 
opioids inhibit the inhibitory interneurons, which thereby 
exacerbate the epileptic seizure rather than inhibiting it. 
DOR exerts suppressive epileptic activities in cortical 
regions trough inhibiting sodium channels. Interestingly, 
researchers have reported that if DOR is down-regulated 
and sodium channels are up-regulated, then it will 
exacerbate epilepsy [21,22]. It is also stated that α2-
adrenoceptors play a dramatic role in modulating the 
anticonvulsant effects of morphine. In addition, agmatine 
that is considered to be used as an adjunct therapy for 
seizure, enhances the anticonvulsant effect of morphine 
through α2-adrenoceptors [23]. Lipopolysaccharide has 
been found to facilitate seizure susceptibility in colonic 
seizure model of mice. This activity was facilitated by 
opioid system along with other molecules such as 
prostaglandins and NO [24].  
 
Morphine and endogenous opioids possess 
anticonvulsant effects 
Morphine is the main psychoactive chemical agent 
in opium used in certain clinical conditions. Since its 
discovery dates back to almost 210 years ago, it was 
found that morphine exhibits anticonvulsant effect. Some 
clinical trials report the anticonvulsant properties of 
morphine as well [25]. Various experimental studies 
have also shown the anticonvulsant effects of morphine. 
For instance, morphine was found to delay the onset of 
PTZ-induced seizures in experimental animal models of 
seizure [1]. These results were further confirmed by the 
study where the subcutaneous administration of acute 
lower doses of morphine (0.5, 1, and 3 mg/kg) postponed 
the onset of PTZ-induced seizure [7]. Similarly, morphine 
decreases the intensity of maximal electroshock 
seizures[26]. Acute doses of morphine also illustrate an 
anticonvulsant effect against various seizure models 
induced by gamma-Aminobutyric acid (GABA) 
transmission blockers, such as picrotoxin, bicuculline, 
PTZ, and isoniazid [27]. Similar to morphine, other 
opioids such etorphine and β-endorphin also increase 
the seizure threshold and demonstrate anticonvulsant 
effects [28,29]. Different species may respond 
asymmetrically to these effects. For example, morphine 
acts as a proconvulsant to PTZ-induced seizure model 
of mice [30], while on the contrary, it might act as an 
anticonvulsant following  PTZ administration in rat model 
[31]. 
 
Morphine and endogenous opioids possess 
proconvulsant effects 
Previously, it was reported that morphine under certain 
conditions, shows anticonvulsant effects. However, in 
contrast, morphine also exerts proconvulsant effects 
under certain conditions, for instance, when a high 
systemic dose of morphine is used. Data from the 
previous research, found that epileptiform patterns and 
behavioral convulsions may be exacerbated by high 
doses of morphine in various experimental animals such 
as rabbits [32], mice [30], monkeys [33], and even in 
humans. Morphine can also initiate electrographic  
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seizures in rats following intracerebroventricular injection 
at high doses [34]. We also reported that apart from the 
proconvulsant behavior, morphine when used in 
subeffective proconvulsant dose, could enhance the 
proconvulsant effects of Sildenafil [14]. Surprisingly, we 
showed that injection of anticonvulsant dose of morphine 
(1mg/kg) in post weaning social isolation stress model in 
mice, exerts proconvulsant effects.  It might be due to 
dysregulation of opioid system in these animals induced 
by social isolation stress thus mediating the opposite 
response [35]. Considering the diversity of proconvulsant 
and anticonvulsant effects of morphine we can assume 
that these opposite effects might be mediated through 
different mechanisms, sites, and receptors. Table 1 
shows anticonvulsant and proconvulsant properties of 
opioids. 
 
Opioid receptors and seizure 
Opioid receptors are expressed in different parts of the 
brain. In majority of experimental models of seizure, both 
the proconvulsant and anticonvulsant effects are shown 
to be linked with these receptors. Morphine exerts both 
anticonvulsant (1, 3, and 7.5 mg/kg, i.p.) and 
proconvulsant (30 and 60 mg/kg, i.p.) effects in similar 
seizure models. In addition, we showed that 
glibenclamide at higher doses (2.5-5 mg/kg) amplified 
the PTZ-induced seizure threshold, while in lower dose 
(1 mg/kg) interestingly suppressed both anticonvulsant 
and proconvulsant effects of morphine. However, 
cromakalim (1 µg/kg) reversed these responses [36]. 
There is well-documented interaction between 
endogenous opioids and cannabinoids [37]. 
Cannabinoids itself is thought to participate in 
susceptibility of seizure in various animal models. The 
opioid receptors antagonist, naltrexone or cannabinoid 
CB1 receptor inverse agonist could reverse the 
increased seizure threshold, which might be attributed 
either by GABAergic synapses up-regulation or down-
regulation of glutamate synapses [38]. This question 
needs to be addressed that why the different doses of 
the same drug make different responses, while 
interacting with same opioid system. Answering this 
question may open new ways to development of new 
efficient therapeutic targets in seizure treatment. 
 
Opioid receptors involved in anticonvulsant effects 
Evidence shows the involvement of opioid receptors in 
anticonvulsant effects of opioids. For example, it is 
reported that dynorphin regulates the hippocampal 
excitability, thereby producing anticonvulsant effects by 
interacting with KOR [39]. We previously showed that 
anticonvulsant effect of a low dose of 
morphine(100µg/kg) was significantly boosted by 
systemic administration of low dose of the opioid 
receptor antagonist, naltrexone (10 mg/kg) [5]. It is also 
reported that selective MOR antagonist cyprodime 
(3mg/kg,i.p.) and opioid antagonist naltrexone (0.3, and 
1mg/kg,i.p.) markedly inhibited the increase in 
electroshock seizure threshold, which was induced by 
phenytoin (3mg/kg,i.p.) [40]. Our lab also reported that in 
cholestatic mice, the levels of endogenous opioids 
increase, which boost the PTZ-induced seizure threshold 
in cholestasis [3]. 
 
Opioid receptors involved in proconvulsant effects 
Different opioid receptors are involved in mediating the 
proconvulsant effects of morphine and other related 
opioids. It is reported that neuroexcitatory action of 
morphine in spontaneous seizure activity is mediated via 
selective stimulation of the MOR and KOR subtypes, but 
not by DOR subtype [20]. We have shown that 
subcutaneous administration of morphine increased 
sensitization to PTZ-induced clonic seizures through 
interaction with MOR [41]. These findings were 
replicated in our further experiments [1,42]. However, 
some investigators disproved this hypothesis and 
reported an increase in proconvulsant effects of the 
opioid antagonist. Thus, after systemic administration of 
morphine, nalorphine in spite of blocking the behavioral 
convulsions in mice and rats, shortened  the  onset  of  
seizure [43,44].  The levels of sex hormones affect the 
seizure threshold as for instance,  in our study we 
reported that diestrus mice are more susceptible to 
anticonvulsant effect of morphine [45]. It shows that sex 
difference may also have some effects on opioids in 
modulating seizure. Convulsions also occur because of 
hyperactivity of N-methyl-D-aspartate (NMDA) receptor 
in MOR knockout mice. In MOR knockout mice, it was 
found that activity of NMDA receptor is increased in 
thalamus, hypothalamus, and parietal cortex, which 
resulted in increase in synaptic excitability convulsions 
[46]. 
 
Opioids and nitric oxide (NO) interaction 
Opioids along with NO possess dramatic role in various 
biological functions such as pain, reward, addiction, 
depression, and seizure [47-54]. Opioid system interacts 
with NO in certain physiological functions. NO is an 
unstable signaling molecule helpful in implicating diverse 
physiological functions such as memory, learning, and 
neurogenesis, as well as seizure, depression, and other 
neurological disorders [55-58]. It is formed from L-
arginine endogenously by various isoforms of nitric oxide 
synthase (NOS) enzymes expressed in different parts of 
the body including brain [59-61]. Some reports including 
from our lab demonstrated that NO and opioids interact 
together in various conditions including memory, ethanol 
gastric damage, cholestasis, morphine tolerance, pain, 
and seizure [1,10,47,48,61-77]. In seizure, the effect of 
NO are still unclear as it shows ambiguous activity in 
seizure modulation when interacting with opioids and 
their receptors. It has been shown that under certain 
laboratory protocol for seizure, NO may mimic the 
anticonvulsant effects of opioids, while in other set of 
conditions, it reverses the anticonvulsant properties of 
opioids [3,9]. We also obtained similar results using 
different doses of opioids and its interaction with various 
receptors [6,8]. Moreover, we reported that co-
administration of subeffective doses of morphine (0.1 
and 0.5 mg/kg) with the NOS inhibitor, Agmatine 
(3 mg/kg) enhances anticonvulsant effects, while the NO 
precursor, L-arginine (30 and 60 mg/kg) reverse this 
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response. This shows that agmatine boosts the 
anticonvulsant effects of morphine through NO pathway 
in experimental seizure model in mice [78]. Similarly, it 
was shown that proconvulsant effects of chloroquine are 
mediated through opioid system and neuronal nitric 
oxide synthase (nNOS) enzyme [79]. Hence, these 
reports confirm that there is a strong co-relationship 
between opioidergic and nitrergic systems in modulation 
of seizure susceptibility. Some evidence shows an 
ambiguous effect of opioids on NOS activity. However, 
most opioids (MOR and DOR agonists) stimulate NOS 
activity [61,80,81], while KOR agonists are reported to 
inhibit the activity of NOS [82,83]. Figure 1 illustrates the 
interaction between opioids and NO. 
 
Nitric oxide and its effect on seizure threshold 
Epilepsy comprises a group of related disorders 
characterized by a tendency for recurrent seizures. NO 
is retrograde neurotransmitter that regulates brain 
excitability and seizure threshold in various experimental 
models of seizure [84]. Research from our laboratory 
show the involvement of NO in modulation of seizure 
susceptibility using various drugs treatment. We recently 
found that NO plays a crucial role in serotonin-5-HT3 
receptor activation, which leads to anticonvulsant 
responses in PTZ-induced seizure [85,86]. Furthermore, 
our recent experiment revealed that NOS inhibitors, L-
NG-Nitro arginine methyl ester (L-NAME) and 7-
Nitroindazole (7-NI) alone or in combination with low 
dose of 5-HT3 receptor agonist enhanced anticonvulsant 
properties of citalopram, which corroborated our 
aforementioned studies [87]. In addition, the possible 
role of peroxisome proliferator-activated receptor 
gamma (PPAR-γ) and NO pathway in PTZ-induced 
seizure has been reported. Using PPAR-γ agonist 
exerted anticonvulsant effect while PPAR-γ antagonist or 
L-NAME could reverse this effect. Hence, it implicate the 
involvement of NO system in this response [88]. 
Additionally, recently it was reported that hippocampal 
NO levels are involved in proconvulsant effects of social 
isolation stress (SIS) in postnatal mice [89]. 
 
Figure 1: Opioids and Nitric oxide interaction. MOR: mu opioid 
receptor, DOR: Delta opioid receptor, KOR: Kappa opioid receptor, 
NOS: Nitric oxide synthase, BH4: Tetrahydrobiopterin, NADPH: 
Nicotinamide adenine dinucleotide phosphate, NO: nitric oxide. 
Proconvulsant effects of Nitric oxide 
NO exerts both proconvulsant and anticonvulsant 
activities in seizure occurrence. Most of literature review 
reports the proconvulsant effects of NO. For instance, we 
have shown that anticonvulsant effects of thalidomide is 
mediated by modulation of nNOS enzyme [90]. Similarly, 
evidence show that NOS inhibitors such as L-NAME 
diminish the seizure induced by cocaine or NMDA 
[91,92]. Akula et al. showed that the NO precursor, L-
arginine reverses the anticonvulsant effect of adenosine, 
while on the other hand, NOS inhibitors, L-NAME and 7-
NI potentiate this effect [93]. An interesting research 
about the sex differences in seizure susceptibility 
revealed that NO mediate seizure in both sexes, while 
males are more susceptible to seizure [94]. Licofelone as 
a dual cyclooxygenase (COX) /5-lipoxygenase (5-LOX) 
inhibitor is recently reported to possess analgesic and 
anti-inflammatory properties. Our recent experiment also 
revealed the neuroprotective and anticonvulsant effects 
of this agent through downregulation of inducible nitric 
oxide synthase (iNOS) enzyme [95]. We also reported 
that the COX-2 inhibitor, celecoxib exerts an 
anticonvulsant effect in clonic seizure threshold through 
inhibition of NO pathway [96]. 
 
Anticonvulsant effects of nitric oxide 
Beside the proconvulsant affects of NO, various 
investigations have reported the anticonvulsant actions 
of this neurotransmitter. Starr et al. reported that NO 
normally suppresses epileptogenesis in pilocarpine-
induced limbic epilepsy in mice [97]. Buisson et al. have 
also shown that injection of NOS inhibitors deteriorates 
the seizure induced by intracerebroventricular injection 
of NMDA [84]. It is suggested that NO can increase the 
cerebral blood flow and acts as anticonvulsant in 
bicuculline-induced seizure [98]. It was also shown that 
α-tocopherol could reverse penicillin-induced 
epileptiform electrocorticographical activity in rats 
through NO formation [99]. Moreover, we reported that 
cannabinoid CB1 receptor agonist postponed the 
occurrence of PTZ-induced seizure through nitrergic 
system [100]. We also showed that neuroprotective and 
anticonvulsant properties of acute and chronic 
administration of atorvastatin in electroshock and PTZ 
seizure models is at least in part due to iNOS activity 
[101,102]. Our recent experiments concluded that acute 
and subchronic administrations of the antipsychotic 
agent, aripiprazolein chemically- and electrically-induced 
seizures in mice are linked to release of NO induced by 
iNOS and nNOS enzymes [103,104]. Hence, this 
literature review suggests that NO possesses 
anticonvulsant properties too. Table 2 demonstrates 
proconvulsant and anticonvulsant properties of NO. 
 
Opioids/Nitric oxide and seizure 
Opioidergic and nitrergic systems are among the highly 
studied systems which affect seizure threshold. 
Evidence shows the correlation between opioidergic and 
nitrergic systems in dual modulation of seizure by various 
drugs. Research from our laboratory revealed that 
 




                     Advancements in Life Sciences  |  www.als-journal.com  |  August 2020  | Volume 7  |  Issue 4                        197           
 

















































subeffective dose of lithium could inhibit both 
proconvulsant and anticonvulsant effects of morphine in 
clonic seizure threshold in mice. We suggested that 
blockade of opioid receptors signaling probably through 
activation of nitrergic system might mediate these effects 
of lithium [1]. We also showed that melatonin boosts both 
proconvulsant and anticonvulsant effects of morphine 
possibly through activation of nitrergic system. However, 
possible pharmacokinetic interaction between melatonin 
and morphine cannot be ruled out in enhancement of two 
opposing effects of morphine on seizure threshold [73]. 























mediated by activation of NO pathway through classic 
opioid receptors [105]. 
Conclusion 
This review has focused on the interaction between 
opioid and nitrergic systems in modulating the seizure 
threshold in various experimental paradigms of seizure. 
Such information could clarify that how seizures respond 
to different opioids and what is the impact of NO levels 
on seizure threshold. Morphine exerts dramatic 
proconvulsant and anticonvulsant effects depending on 
dose and conditions. It is concluded that morphine can 
provoke electrogenic convulsions when administered 
Species Seizure induction model Drug Dose Results Reference 
Mice PTZ Morphine 1 mg/kg, IP Anticonvulsant [1] 
Mice PTZ Morphine 0.5-3 mg/kg, SC Anticonvulsant [7] 



































Rats Flurothyl Etorphine 0.05–1.6 μg, ICV Anticonvulsant [28] 
Gerbils Genetic β-endorphin 0.1–3 μg,  ICV Anticonvulsant [29] 
Rats PTZ Morphine 5-15 mg/kg, IP Anticonvulsant [31] 
Mice - Morphine 15-100 mg/kg, IP Proconvulsant [30] 
Mice - Morphine 30 mg/kg, IP Proconvulsant [1] 
Rats - Morphine 10 mg/kg, IP Proconvulsant [34] 
Species Seizure induction model Drug Dose Results Reference 
Mice PTZ Morphine 1 mg/kg, IP Anticonvulsant [1] 
Mice PTZ Morphine 0.5-3 mg/kg, SC Anticonvulsant [7] 



































Rats Flurothyl Etorphine 0.05–1.6 μg, ICV Anticonvulsant [28] 
Gerbils Genetic β-endorphin 0.1–3 μg,  ICV Anticonvulsant [29] 
Rats PTZ Morphine 5-15 mg/kg, IP Anticonvulsant [31] 
Mice - Morphine 15-100 mg/kg, IP Proconvulsant [30] 
Mice - Morphine 30 mg/kg, IP Proconvulsant [1] 
Rats - Morphine 10 mg/kg, IP Proconvulsant [34] 
Table 1: Anticonvulsant and proconvulsant properties of opioids. 
Species Seizure induction model Results Reference 
Mice - Proconvulsant [90] 
Rats - Proconvulsant [91] 
Mice - Proconvulsant [92] 
Mice - Proconvulsant [93] 
Mice - Proconvulsant [94] 
Mice - Proconvulsant [95] 
Mice - Proconvulsant [96] 
Mice Pilocarpine Anticonvulsant [97] 
Rats Bicuculline Anticonvulsant [98] 
Rats Penicillin Anticonvulsant [99] 
Mice PTZ Anticonvulsant [107] 
Table 2: Proconvulsant and anticonvulsant properties of Nitric oxide. 
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systemically in high doses. This effect seems to be 
initiated by another system rather than opioid receptors, 
since opioid antagonist fails to reverse it. 
Pharmacological evidence supports that 
intracerebroventricular injection of morphine triggers 
convulsive behavior through MOR and DOR opioid 
receptors. Conversely, the anticonvulsant effect of 
morphine is also reported to be mediated through MOR. 
Nitrergic system also exerts both proconvulsant and 
anticonvulsant effects for various drugs through different 
NOS isoenzymes in diverse animal models and 
conditions. Since, evidence show ambiguous results 
about the involvement of opioidergic and nitrergic 
systems in seizure mechanisms, site of action, and type 
of seizures, hence, this system is still highly challenging. 
Future investigations might elucidate the exact 
mechanisms explaining the anticonvulsant and 
proconvulsant effects of opioidergic and nitrergic 
systems interaction in seizure. 
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